封面
市场调查报告书
商品编码
1859466

新冠病毒检测套组市场规模、份额、成长分析(依产品类型、检体/样本类型、最终用户、检测模式、地区划分)-2025-2032年产业预测

COVID Testing Kit Market Size, Share, and Growth Analysis, By Product Type, By Specimen / Sample Type, By End-User, By Mode of Testing, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 191 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球新冠病毒检测套组市场预计到 2023 年将达到 801 亿美元,从 2024 年的 861.9 亿美元成长到 2032 年的 1,548.6 亿美元,在预测期(2025-2032 年)内复合年增长率为 7.6%。

全球新冠病毒检测套组市场正因数位医疗解决方案和电子商务的兴起而发生变革,其中,自测检测套组因其便利性而日益普及,尤其是在都市区。鼻拭子和唾液检测也因其易用性而广受欢迎。业内公司正致力于研发能够检测多种呼吸道病毒的多重诊断技术,而卫生部门也因其成本效益而对其需求不断增长。此外,人工智慧技术的应用提高了检测准确性并缩短了检测週期,从而增强了消费者对居家检测和实验室检测的信心。儘管面临市场饱和和成本压力等挑战,但对新冠病毒检测套组的需求仍然强劲,随着行动医疗医疗和诊断技术的不断创新,该市场展现出巨大的成长潜力。

全球新冠病毒检测套组市场驱动因素

全球新冠病毒检测套组市场的主要驱动因素之一是,随着世界持续应对新冠疫情及其变种,对快速、准确的诊断工具的需求不断增长。人们日益认识到早期检测在控制疫情的重要性,促使医疗机构、政府和个人将检测列为优先事项。家用检测套组的兴起提供了便利性和可及性,满足了更广泛人群的需求。此外,检测技术的不断进步,例如高灵敏度和高特异性检测方法的开发,进一步推动了市场成长,并满足了全球医疗保健系统的多样化需求。

全球新冠病毒检测套组市场面临的限制因素

全球新冠病毒检测套组市场面临许多限制因素,包括监管挑战和各地区标准不一。检测套组的核准流程漫长而复杂,可能导致产品上市延迟。此外,品管和准确性标准的差异会削弱公众对检测方案的信任,阻碍其广泛应用。这些因素,加上其他诊断方法的出现和政府优先事项的转变,也可能分散检测项目的资金和关注。因此,製造商必须应对复杂的合规和市场接受度挑战,这影响了其成长潜力。

全球新冠病毒检测套组市场趋势

全球新冠病毒检测套组市场正经历着向自我检测和居家诊断的重大转变,这主要得益于消费者对分散式医疗解决方案日益增长的需求。随着监管核准的不断扩大,基于唾液的自我检测抗原试剂套件因其易用性、价格实惠以及减少就医次数等优势,尤其是在感染疾病再次爆发期间,正受到消费者的青睐。这一趋势反映了消费者在医疗保健管理方面对便利性和自主性的日益偏好,显着影响着市场动态并推动产品研发的创新。对快速可靠检测方式的日益重视正在改变新冠病毒检测格局,增强市场的韧性和适应性。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2024)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管环境
  • 客户和购买标准分析
  • 原料分析

新冠病毒检测套组市场规模(依产品类型划分)及复合年增长率(2025-2032 年)

  • 市场概览
  • RT-PCR检测试剂套件
  • 免疫检测测定试纸/试剂盒
  • 基于CRISPR的分子诊断套件
  • 其他分子检测套件

新冠病毒检测套组市场规模(依检体/样本类型划分)及复合年增长率(2025-2032 年)

  • 市场概览
  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 唾液样本
  • 血液/指尖采血

新冠病毒检测套组市场规模(依最终用户划分)及复合年增长率(2025-2032 年)

  • 市场概览
  • 医院和诊所
  • 诊断实验室
  • 居家护理/自我检查
  • 公共卫生机构
  • 其他的

新冠病毒检测套组市场规模(依检测模式划分)及复合年增长率(2025-2032 年)

  • 市场概览
  • 集中式实验室检测(非即时检测)
  • 照护现场侦测 (POC)
  • 商店(OTC)自测

新冠病毒检测套组市场规模及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2024 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2024 年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2022-2024年营收年比比较

主要企业简介

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • BGI Group
  • Qiagen
  • Quidel Corporation
  • Mylab Discovery Solutions
  • SD Biosensor
  • BioMerieux SA
  • Danaher Corporation
  • Hologic Inc.
  • Seegene Inc.
  • PerkinElmer Inc.
  • Randox Laboratories
  • CEPI(Collaborative entities)
  • Guangzhou Wondfo Biotech
  • Shenzhen Bioeasy Biotechnology
  • Cepheid Inc.
  • 1drop Inc.
  • ADT Biotech

结论与建议

简介目录
Product Code: SQMIG35J2168

Global COVID Testing Kit Market size was valued at USD 80.1 billion in 2023 and is poised to grow from USD 86.19 billion in 2024 to USD 154.86 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global COVID testing kit market is witnessing a transformation driven by digital health solutions and the rise in e-commerce, particularly in urban areas where self-test kits are gaining popularity for their convenience. Nasal swab and saliva tests are favored for their ease of use. Industry players are focusing on multiplex diagnostics that can detect multiple respiratory viruses, which are increasingly sought by health authorities due to their cost-effectiveness. Furthermore, the integration of AI technology enhances testing accuracy and reduces turnaround times, bolstering consumer confidence in both home and lab testing. Despite facing challenges such as market saturation and cost pressures, the demand for COVID testing kits remains robust, signaling strong growth potential as innovations in mobile healthcare and diagnostics continue to develop.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global COVID Testing Kit market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global COVID Testing Kit Market Segments Analysis

Global COVID Testing Kit Market is segmented by Product Type, Specimen / Sample Type, End-User, Mode of Testing and region. Based on Product Type, the market is segmented into RT-PCR Assay Kits, Immunoassay Test Strips / Cassettes, CRISPR-Based Molecular Kits and Other Molecular Kits. Based on Specimen / Sample Type, the market is segmented into Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Saliva Sample and Blood / Finger-Prick. Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care / Self-Testing, Public Health Agencies and Others. Based on Mode of Testing, the market is segmented into Centralized Lab Testing (Non-POC), Point-of-Care (POC) Testing and Over-The-Counter (OTC) Self-Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global COVID Testing Kit Market

One of the key market drivers for the Global COVID Testing Kit Market is the increasing demand for rapid and accurate diagnostic tools as the world continues to navigate through the pandemic and its variants. Growing awareness of the importance of early detection in managing outbreaks has propelled healthcare providers, governments, and individuals to prioritize testing. The rise in home testing kits offers convenience and accessibility, catering to a broader population. Additionally, continuous advancements in testing technology, including the development of highly sensitive and specific assays, further enhance the market's growth, addressing the diverse needs of healthcare systems globally.

Restraints in the Global COVID Testing Kit Market

The global COVID testing kit market faces significant restraints due to regulatory challenges and varying standards across different regions. The approval processes for testing kits can be lengthy and complex, leading to delays in product availability. Additionally, disparities in quality control and accuracy standards can undermine public confidence in testing solutions, hampering widespread adoption. These factors are compounded by the emergence of alternative diagnostic methods and shifting governmental priorities, which may divert funding and focus away from testing initiatives. Consequently, manufacturers must navigate a complicated landscape of compliance and market acceptance, impacting their growth potential.

Market Trends of the Global COVID Testing Kit Market

The Global COVID Testing Kit market is witnessing a significant shift towards self-testing and home diagnostics, spurred by a growing demand for decentralized healthcare solutions. As regulatory approvals expand, self-administered saliva-based antigen kits are gaining popularity among consumers due to their ease of use, affordability, and reduced clinic interaction, particularly during resurgences of infections. This trend reflects a broader consumer preference for convenience and autonomy in health management, significantly influencing market dynamics and encouraging innovations in product development. The emphasis on rapid, reliable testing options is reshaping the landscape of COVID testing, reinforcing the market's resilience and adaptability.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis
  • Raw Material Analysis

Global COVID Testing Kit Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • RT-PCR Assay Kits
  • Immunoassay Test Strips / Cassettes
  • CRISPR-Based Molecular Kits
  • Other Molecular Kits

Global COVID Testing Kit Market Size by Specimen / Sample Type & CAGR (2025-2032)

  • Market Overview
  • Nasopharyngeal Swab
  • Oropharyngeal Swab
  • Nasal Swab
  • Saliva Sample
  • Blood / Finger-Prick

Global COVID Testing Kit Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care / Self-Testing
  • Public Health Agencies
  • Others

Global COVID Testing Kit Market Size by Mode of Testing & CAGR (2025-2032)

  • Market Overview
  • Centralized Lab Testing (Non-POC)
  • Point-of-Care (POC) Testing
  • Over-The-Counter (OTC) Self-Testing

Global COVID Testing Kit Market Size & CAGR (2025-2032)

  • North America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • US
    • Canada
  • Europe (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylab Discovery Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SD Biosensor
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seegene Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CEPI (Collaborative entities)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guangzhou Wondfo Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Bioeasy Biotechnology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 1drop Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ADT Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations